Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-
Go back to Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-| (NASDAQ: LQDA) | Delayed: 74.04 -1.45 (1.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $75.49 | 52 Week High | $ | |||
| Open | $74.33 | 52 Week Low | $ | |||
| Day High | $77.09 | P/E | N/A | |||
| Day Low | $73.80 | EPS | $ | |||
| Volume | 1,706,002 | |||||
